Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aude-Anaïs Olijnik

BSc Cell Biology and Physiology, MSc Microbiology and Omics

Research Assistant

My research focuses on understanding the molecular basis of a rare type of anaemia called Congenital Dyserythropoietic Anaemia type I (CDA-I). This disease is due to abnormal erythropoiesis where erythroblasts cannot mature into erythrocytes. CDA-I patients show a wide range of symptoms; some can have a life-long dependency on transfusion while others will have less severe symptoms. Diagnosis relies on analysing bone-marrow aspirate by looking for inter-nuclear bridges and bi-nucleated or multinucleated erythroblasts and electron microscopy shows a characteristic pattern of spongy (“Swiss cheese”) heterochromatin in the erythroblast nucleus.


Our lab has previously identified a gene mutated in some CDA-I patients that codes for the protein C15orf41. There is a second protein also involved in CDA-1 called Codanin-1. These two proteins are localised predominantly in the nucleoli and are hypothesised to have a role in the resolution of abnormal chromatin structures. My work focuses on deciphering the role of these proteins during normal erythropoiesis and how mutant versions impact the differentiation of erythroblasts.


I am using a cell line called HUDEP-2 (Human Umbilical cord-Derived Erythroid Progenitor-2) to study the function of C15orf41 and Codanin-1 at different stages of erythropoiesis
To assist in this aim I am engineering an endogenously tagged version of C15orf41 in HUDEP-2 cells using CRISPR-Cas9 technology and am introducing patient mutations into this cell line to establish a cellular model for the disease.
Since neither protein is abundant in the cell, I have developed a protocol for 2-colour Infrared-Western Blotting of lowly expressed proteins to study Codanin-1 and C15orf41 in HUDEP-2 cells and in primary CD34+ cells.


As an additional project, I am looking for biomarkers for CDA-1 that could give a more reliable and more rapid diagnosis than microscopic studies. Such a biomarker could also facilitate screening for improved therapies for this serious disease. 

2-colour Infrared Western-Blot of lowly expressed proteins